A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EC / endometrial carcinoma

[Related PubMed/MEDLINE]
Total Number of Papers: 591
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EC  (>> Co-occurring Abbreviation)
Long Form:   endometrial carcinoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A multiomics comparison between endometrial cancer and serous ovarian cancer. OVCA, SM
2020 Adjuvant chemotherapy in endometrial cancer. CT, EBRT, LVSI, MI, VBT
2020 Combining Bioinformatics and Experiments to Identify and Verify Key Genes with Prognostic Values in Endometrial Carcinoma. DEGs, GO, PPI, UBE2C
2020 DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics. HG-ESS, LGESS, ULMO, ULMS, UTROSCT
2020 Granular dot-like staining with MLH1 immunohistochemistry is a clone-dependent artefact. CRC, IHC, MSI
2020 Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network. ceRNA, DElncRNAs, DEmiRNAs, DEmRNAs, lncRNAs, miRNAs, mRNAs
2020 Increasing incidence of endometrial carcinoma in a high-risk New Zealand community. APC
2020 LncRNA PCAT1 promotes metastasis of endometrial carcinoma through epigenetical downregulation of E-cadherin associated with methyltransferase EZH2. ---
2020 MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway. MELK
10  2020 PD-L1 Expression in Endometrial Carcinoma Cells and Intratumoral Immune Cells: Differences Across Histologic and TCGA-based Molecular Subgroups. Ca, CPS, ICs, PD-L1, POLE
11  2020 Performance Characteristics of Endometrial Sampling in Diagnosis of Endometrial Carcinoma. AH
12  2020 The Significance of Galectin-1 and Galectin-9 Expression in Endometrial Carcinoma. AH, NE
13  2019 A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma. COEUR, HR, SATB2
14  2019 A Matched Analysis on the Prognostic Impact of Race on Survival Endpoints of Women with Early-Stage Endometrial Cancer. AA, DSS, LVSI, NAA, OS, RFS
15  2019 An elevated preoperative serum calcium level is a significant predictor for positive peritoneal cytology in endometrial carcinoma. CA, CEA, LVSI
16  2019 beta-arrestin-2 up-regulates toll-like receptor 2 signaling and inhibits apoptosis in human endometrial cancer heterotransplants in nude mice. Arr2, GSK3beta, TLR2
17  2019 CARLo-5 as an oncogenic gene in endometrial carcinoma. ---
18  2019 Chronic BDE-47 Exposure Aggravates Malignant Phenotypes and Chemoresistance by Activating ERK Through ERalpha and GPR30 in Endometrial Carcinoma. ERalpha, GPR30, PBDEs
19  2019 Clinical and prognostic value of 18F-FDG PET/CT in recurrent endometrial carcinoma. OS, PFS
20  2019 Clinical comparison between neuroendocrine and endometrioid type carcinoma of the uterine corpus. NET-U, OS
21  2019 Clinicopathologic characteristics, tumor infiltrating lymphocytes and programed cell death ligand-1 expression in 162 endometrial carcinomas with deficient mismatch repair function. dMMR, PD-L1, TILs
22  2019 Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas. RFS, SCNAs, SNV
23  2019 Competing endogenous RNA network of endometrial carcinoma: A comprehensive analysis. ceRNA, DElncRNAs, DEmiRNAs, DEmRNAs, DERNAs, lncRNAs, miRNAs, mRNAs
24  2019 Decreased expression of miR-184 restrains the growth and invasion of endometrial carcinoma cells through CDC25A-dependent Notch signaling pathway. 3'-UTR, CDC25A, miR-184
25  2019 Detection of POLE Subtypes in High-Grade Endometrioid Carcinoma by BaseScope-ISH Assay. ISH, POLE
26  2019 Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis. 18FDG PET-CT, AUC, CA125, LNM, MOOSE
27  2019 Diagnostic Variation in p53 Usage for Endometrial Carcinoma Diagnosis: Implications for Molecular Subtyping. HGEC, LGEC
28  2019 Endometrial carcinoma in a 14-year-old: A case report. ---
29  2019 Endometrial carcinoma in a gravid uterus: a case report and literature review. PAS
30  2019 Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics. CCC, EAOC, non-EAOC
31  2019 Establishment of the Prognosis Predicting Signature for Endometrial Cancer Patient. GO, KEGG, OS, RFS
32  2019 Estrogen and insulin synergistically promote endometrial cancer progression via crosstalk between their receptor signaling pathways. ER, INSR
33  2019 Evaluation of HER2/neu Expression in High-Grade Endometrial Carcinoma and Its Clinicopathological Correlation. CCC, DFS, IHC, OS, PSC
34  2019 Expression and clinical significance of KLK5-8 in endometrial cancer. KLK, KLK5-8
35  2019 Expression and potential role of SNF5 in endometrial carcinoma. ---
36  2019 Expression and role of hScrib in endometrium, endometriosis, and endometrial adenocarcinoma. EM, EMS
37  2019 Extended duration of dilator use beyond 1year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy. BT, VD, VS
38  2019 Fertility-Sparing surgery for young women with ovarian endometrioid carcinoma: a multicenteric comparative study using inverse probability of treatment weighting. CRS, FSS, IPTW, OS, RFS
39  2019 Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience. FD, FS, IOE
40  2019 Gene Promoter Methylation in Endometrial Carcinogenesis. AH
41  2019 Germline and somatic mutations of homologous recombination-associated genes in Japanese ovarian cancer patients. CCC, HGSC, HR, LGSC, MC, MMR
42  2019 Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity. HBOC, HEBON
43  2019 Germline POLE and POLD1 proofreading domain mutations in endometrial carcinoma from Middle Eastern region. ---
44  2019 Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition. EMT, ESCs, GOLPH3
45  2019 Hsa_circ_0002577 promotes endometrial carcinoma progression via regulating miR-197/CTNND1 axis and activating Wnt/beta-catenin pathway. circRNA
46  2019 HTLV-1-associated genes as potential biomarkers for endometrial cancer. DEGs, HCA, HTLV-1, SVM
47  2019 Identification of key genes and pathways between type I and type II endometrial cancer using bioinformatics analysis. DEGs, KEGG
48  2019 Immunosuppressive Tumor Microenvironment Status and Histological Grading of Endometrial Carcinoma. ---
49  2019 Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study. CA125, DFS, DSS, FIGO
50  2019 Inflammatory, oxidative stress and anti-oxidative markers in patients with endometrial carcinoma and diabetes. AGEs, AOPP, CRP, FRAP, IL-6, MDA, NO, TNF-alpha
51  2019 Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis. CCC, EAOC, epi, Hb, HNF-1beta, OE
52  2019 International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group. ISGyP
53  2019 Interpretation of somatic POLE mutations in endometrial carcinoma. EDM, MMR-D, MSI, POLE, RFS, TMB
54  2019 Intratumour heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification: a descriptive study. ESC, ITH, MLPA, SCNA
55  2019 Intrauterine Progestin Therapy as a New Approach to Premalignant Endometrial Polyps: A Prospective Observational Study. EHP, LNG-IUS
56  2019 Isolated acrometastasis: A rare presenting feature of endometrial carcinoma. ---
57  2019 Knockdown of differentiation antagonizing non-protein coding RNA exerts anti-tumor effect by up-regulating miR-214 in endometrial carcinoma. CCK-8, DANCR, lncRNA, miRNA, siRNA
58  2019 Knockdown of lncRNA TDRG1 Inhibits Tumorigenesis in Endometrial Carcinoma Through the PI3K/AKT/mTOR Pathway. CCK-8
59  2019 Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B. ChIP, MPA, PRB
60  2019 Knocking down of LINC01220 inhibits proliferation and induces apoptosis of endometrial carcinoma through silencing MAPK11. CCK-8, FIGO
61  2019 LncRNA CCAT1 negatively regulates miR-181a-5p to promote endometrial carcinoma cell proliferation and migration. CCAT1, lncRNAs
62  2019 LncRNA miR143HG Up-Regulates p53 In Endometrial Carcinoma By Sponging miR-125a. ---
63  2019 lncRNA SNHG5 Modulates Endometrial Cancer Progression via the miR-25-3p/BTG2 Axis. ---
64  2019 Long Noncoding RNA HOTAIR Promotes Endometrial Carcinoma Cell Proliferation by Binding to PTEN via the Activating Phosphatidylinositol 3-Kinase/Akt Signaling Pathway. HOTAIR, lncRNAs, PI3K
65  2019 Long noncoding RNA LSINCT5 promotes endometrial carcinoma cell proliferation, cycle, and invasion by promoting the Wnt/beta-catenin signaling pathway via HMGA2. lncRNA, PI
66  2019 Long noncoding RNA TUSC7 inhibits cell proliferation, migration and invasion by regulating SOCS4 (SOCS5) expression through targeting miR-616 in endometrial carcinoma. lncRNA, miR-616, TUSC7
67  2019 Loss of the p53 transactivation domain results in high amyloid aggregation of the Delta40p53 isoform in endometrial carcinoma cells. FL
68  2019 Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results. BAGP, IHC, ISGyP, LS, MMR, OC
69  2019 Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary. CCC, CI, HWR, MRI, OR
70  2019 Maximizing Sentinel Lymph Node Detection: Aortic Sentinel Lymph Node Detection in Endometrial Cancer. ICG, SLNs
71  2019 MicroRNA-103 regulates the progression in endometrial carcinoma through ZO-1. ---
72  2019 MicroRNA-202 inhibits cell migration and invasion through targeting FGF2 and inactivating Wnt/beta-catenin signaling in endometrial carcinoma. EMT, FGF-2, miR-202, miRNAs
73  2019 MicroRNA-93-5p/IFNAR1 axis accelerates metastasis of endometrial carcinoma by activating the STAT3 pathway. CCK-8, qRT-PCR
74  2019 MicroRNA‑195 inhibits epithelial‑mesenchymal transition by targeting G protein‑coupled estrogen receptor 1 in endometrial carcinoma. EMT, MMP
75  2019 MiR-182 promotes cell proliferation, migration and invasion by targeting FoxF2 in endometrial carcinoma cells. ---
76  2019 MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4. EMT, IHC, miRNAs, RIP, SOX4
77  2019 miR-940 potentially promotes proliferation and metastasis of endometrial carcinoma through regulation of MRVI1. OS
78  2019 miRNA-mRNA Associated With Survival in Endometrial Cancer. DEGs, DEmiRNAs, DEmRNAs
79  2019 miR‑107‑5p promotes tumor proliferation and invasion by targeting estrogen receptor‑alpha in endometrial carcinoma. ERalpha
80  2019 MMR deficient undifferentiated/dedifferentiated endometrial carcinomas showing significant programmed death ligand-1 expression (sp 142) with potential therapeutic implications. MMR, PD-L1
81  2019 Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: A prospective multicentre cohort study. ---
82  2019 Nuclear beta-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome. CI, HR, OCSS
83  2019 Nuclear expression of beta-catenin in endometrial hyperplasia as marker of premalignancy. DOR, EH, NE, OR
84  2019 Oncologic Outcome of Patients with (Low-Risk) Endometrial Carcinoma Undergoing Laparotomy versus Minimally Invasive Hysterectomy: A Retrospective Analysis. LAP, MIH
85  2019 Outcomes of in vitro fertilization cycles following fertility-sparing treatment in stage IA endometrial cancer. IVF
86  2019 Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions. IHC
87  2019 p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies. IHC, MMRd, NGS, POLEmut
88  2019 Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade). ---
89  2019 PCAT1 is a poor prognostic factor in endometrial carcinoma and associated with cancer cell proliferation, migration and invasion. Bad, Bcl-2, lncRNAs, PCAT1, RT-qPCR, siRNA
90  2019 Poor outcome in hypoxic endometrial carcinoma is related to vascular density. CAIX, DDFS, DFS, DSS, HR, MVD
91  2019 Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma. ER, FIGO, HER2, LN, LVSI, PR
92  2019 Pretreatment thrombocytosis predict poor prognosis in patients with endometrial carcinoma: a systematic review and meta-analysis. CIs, DFS, HR, OR, OS
93  2019 Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer. MTV, pT1, TLG
94  2019 Prognostic value of metabolic tumor volume and total lesion glycolysis from ⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma. LNMs, MI, MTV, TLG
95  2019 Risk of postmenopausal hormone therapy and patient history factors for the survival rate in women with endometrial carcinoma. BMI, HT, OS, PFS
96  2019 RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma. DFS, FIGO, OS, RRBP1
97  2019 Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas invitro and invivo. ADC, ADCC, SG, Trop-2
98  2019 Selective vs Complete Sampling in Hysterectomy Specimens Performed for Atypical Hyperplasia. ---
99  2019 Serum calcium is a novel parameter to assess metabolic syndrome in endometrial carcinoma. EEC, FPG, HDL, LDL, NEEC, TC, TG
100  2019 Serum deprivation-response protein regulates aldehyde dehydrogenase 1 through integrin-linked kinase signaling in endometrioid carcinoma cells. ALDH1, ILK, SDPR